Check out Dr. Fabiana Makdissi talking about benefits, recommendations and the impact on quality of life for patients, a topic addressed at the Survivoship panel.
About the speaker
Go to Event details page
See more on breast cancer
PHESGO Training (Pertuzumab and Trastuzumab in fixed dose for subcutaneous use) On October 10th, the national training on Phesgo took place, see below
PHESGO Training (Pertuzumab and Trastuzumab in fixed dose for subcutaneous use) On October 10th, the national training on Phesgo took place, see below
PHESGO Training (Pertuzumab and Trastuzumab in fixed dose for subcutaneous use) On October 10th, the national training on Phesgo took place, see below
PHESGO Training (Pertuzumab and Trastuzumab in fixed dose for subcutaneous use) On October 10th, the national training on Phesgo took place, see below
PHESGO Training (Pertuzumab and Trastuzumab in fixed dose for subcutaneous use) On October 10th, the national training on Phesgo took place, see below
PHESGO Training (Pertuzumab and Trastuzumab in fixed dose for subcutaneous use) On October 10th, the national training on Phesgo took place, see below
Você tem certeza?
Restricted
Bookmarking is available only for logged-in users.
